419 related articles for article (PubMed ID: 12063543)
1. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
4. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines.
Riedel F; Götte K; Goessler U; Sadick H; Hörmann K
Anticancer Res; 2004; 24(4):2179-83. PubMed ID: 15330158
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
10. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
11. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
12. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
DeFatta RJ; Nathan CO; De Benedetti A
Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
[TBL] [Abstract][Full Text] [Related]
15. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
[TBL] [Abstract][Full Text] [Related]
20. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]